Systemic Sclerosis at the Cellular Level: Molecular Pathways of Pathogenesis and its Implication on Future Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|30|3986-3995

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.30, 2009-10, pp. : 3986-3995

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis

By  

Current Medicinal Chemistry, Vol. 22, Iss. 16, 2015-05 ,pp. : 1943-1955

Bentham Science Publishers

Access to resources Recommend Favorite

Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design

By  

Medicinal Chemistry, Vol. 5, Iss. 3, 2009-05 ,pp. : 242-249

Bentham Science Publishers

Access to resources Recommend Favorite

Ontogeny of systemic drug clearance pathways in infants

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Atomic-Level Rational Drug Design

By  

Current Computer - Aided Drug Design, Vol. 2, Iss. 1, 2006-01 ,pp. : 57-81

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1457-1464

Bentham Science Publishers

Access to resources Recommend Favorite